Skip to main navigation Skip to search Skip to main content

Inhibin immunoreactivity in gonadal and non-gonadal tumors

  • F. H. De Jong
  • , A. J. Grootenhuis
  • , J. Steenbergen
  • , F. J. van Sluijs
  • , J. A. Foekens
  • , F. J.W. ten Kate
  • , J. W. Oosterhuis
  • , S. W.J. Lamberts
  • , J. G.M. Klijn

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Inhibin immunoreactivity was estimated in a number of gonadal and non-gonadal tumors. Dog Sertoli cell tumors and human granulosa cell and Leydig cell tumors contained high concentrations of inhibin-like material. Levels, comparable with those in normal testes and ovaries were detected in human testicular non-seminomas and in ovarian cystadenomas, thecomas and adenofibromas. No activity was found in human testicular Sertoli/Leydig cell tumors and seminomas and in ovarian adenocarcinomas, teratomas and a dysgerminoma. Furthermore, human adrenal cortical tissue (tumor and hyperplastic adrenal) contained inhibin immunoreactivity. No activity was found in human tumors of the stomach, gut, liver, kidney, pancreas and mammary gland or in meningiomas. It is concluded that inhibin is not a good marker for specific gonadal tumors. Inhibin might have intratumor actions a growth or differentiation factor.

Original languageEnglish
Pages (from-to)863-866
Number of pages4
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume37
Issue number6
DOIs
Publication statusPublished - 20 Dec 1990
Externally publishedYes

Fingerprint

Dive into the research topics of 'Inhibin immunoreactivity in gonadal and non-gonadal tumors'. Together they form a unique fingerprint.

Cite this